Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares Outstanding
Ratios

Verrica Pharmaceuticals (VRCA) Long-Term Debt Issuances (2021)

Historic Long-Term Debt Issuances for Verrica Pharmaceuticals (VRCA) over the last 1 years, with Q1 2021 value amounting to $5.0 million.

  • Verrica Pharmaceuticals' Long-Term Debt Issuances changed N/A to $5.0 million in Q1 2021 from the same period last year, while for Dec 2021 it was $5.0 million, marking a year-over-year change of. This contributed to the annual value of $44.1 million for FY2023, which is N/A changed from last year.
  • Per Verrica Pharmaceuticals' latest filing, its Long-Term Debt Issuances stood at $5.0 million for Q1 2021.
  • Verrica Pharmaceuticals' Long-Term Debt Issuances' 5-year high stood at $5.0 million during Q1 2021, with a 5-year trough of $5.0 million in Q1 2021.